BURTONSVILLE, Md., Nov. 5, 2018 /PRNewswire/ -- Many breast imaging centers have launched high risk screening clinics to augment their existing services. This has already become the new standard, as ...
For the first time, clinicians and patients will have access to an integrated view of genotype (Myriad’s MyRisk with RiskScore test) and phenotype (Clairity Breast) through MagView’s Luminary Risk ...
(MENAFN- PR Newswire) FULTON, Md., Nov. 1, 2021 /PRNewswire/ -- MagView, the leading provider of solutions for breast center information management, today announced the launch of its new branding ...
MagView has inked a 15,000-square-foot lease with St. John Properties to move its headquarters to Maple Lawn. Medical software company MagView is relocating its 75-worker headquarters to Maple Lawn ...
Clairity – developer of Clairity Breast, the first and only FDA-authorized offering to estimate a woman’s five-year breast cancer risk directly from a routine mammogram For the first time, clinicians ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results